Cargando…
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
AIMS: Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains uncertain whether there is clinically relevant genetic variation in their efficacy. This study of 18 705 individuals aims to identify genetic variants related to the lipid response to simvastatin and assess...
Autores principales: | Hopewell, Jemma C., Parish, Sarah, Offer, Alison, Link, Emma, Clarke, Robert, Lathrop, Mark, Armitage, Jane, Collins, Rory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612775/ https://www.ncbi.nlm.nih.gov/pubmed/23100282 http://dx.doi.org/10.1093/eurheartj/ehs344 |
Ejemplares similares
-
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
por: Hopewell, Jemma C, et al.
Publicado: (2020) -
Assessment of Vascular Event Prevention and Cognitive Function Among Older
Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials
por: Offer, Alison, et al.
Publicado: (2019) -
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
por: Parish, Sarah, et al.
Publicado: (2018) -
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
por: Parish, Sarah, et al.
Publicado: (2022) -
An evaluation of the Hitachi 705 analyser
por: Ferré, C., et al.
Publicado: (1984)